MTOR and neoplasm: The combined use of NCTD and crizotinib can significantly inhibit the growth of tumors in tumor-bearing mice, and the effect is better than that of a single drug, which may be related to NCTD inhibiting the mTOR pathway (Sun et al., 2017).